Belgium· BE-AMP-SAM247545-00
InductOs 1.5 mg/ml
A dibotermin alfa product containing dibotermin alfa, registered in Belgium by Medtronic Biopharma. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Dibotermin alfa is registered in 11 of 19 countries.
Countries holding a registration under ATC M05BC01 (dibotermin alfa), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Dibotermin alfa · ATC M05BC01
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Dibotermin Alfa
- Manufacturer
- Medtronic Biopharma
- Country
- Belgium (BE)
- ATC code
- M05BC01
- ATC class
- Dibotermin alfa
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0789842
- be_apb2068591
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dibotermin alfa in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandInductOs 1.5 mg/ml, poudre 12 mg, solvant et matrice pour matrice pour implantationMedtronic BioPharma Sàrl
- SpainINDUCTOS 1,5 MG/ML POLVO, DISOLVENTE Y MATRIZ PARA MATRIZ DE IMPLANTACIÓNMedtronic Biopharma B.V.
- NorwayInductOsMedTronic BioPharma B.V.
- PolandInductOsMedtronic BioPharma B.V.
- SwedenInductOs 1,5 mg/ml Pulver, vätska och matrix till matrix för implantationMedtronic BioPharma B.V.
- FinlandInductosMedtronic BioPharma B. V.
- CzechiaINDUCTOSMedtronic BioPharma B.V., Heerlen
- United KingdomInductOs 12mg powder and solvent and matrix for implantation matrixMedtronic Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Inductos
- Liechtenstein · Inductos
- Norway · Inductos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4529ca75-ab7f-4e8a-9513-689a2fd6e11e GET /v1/drugs/4529ca75-ab7f-4e8a-9513-689a2fd6e11e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder, solvent and matrix for implantation matrix",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "InductOs 1.5 mg/ml",
"name_fr": "InductOs 1.5 mg/ml",
"name_nl": "InductOs 1.5 mg/ml",
"amp_code": "SAM247545-00",
"strengths": [
"12.0000"
],
"pack_count": 1,
"substances": [
"Dibotermin Alfa",
"Sodium Chloride",
"Sodium Hydroxide",
"Sucrose",
"Polysorbate 80"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Dibotermin Alfa",
"authorisation_numbers": [
"EU/1/02/226/001"
]
}See everything about dibotermin alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.